Results 181 to 190 of about 20,131,715 (394)

Selective Inhibitors of Cyclin G Associated Kinase (GAK) as Anti-Hepatitis C Agents

, 2015
Soňa Kovačková, Lei Chang, Elena Bekerman, Grégory Neveu, Rina Barouch‐Bentov, A. Chaikuad, Christina Heroven, Michal Šála, Steven De Jonghe, Stefan Knapp, Shirit Einav, Piet Herdewijn   +11 more
openalex   +1 more source

Hepatitis C virus point-of-care microelimination approach in a vulnerable population in the South of Spain [PDF]

, 2023
José M. Pinazo-Bandera, Jesús Aranda, Alberto García-García, Ramiro Alcántara, Aida Ortega‐Alonso, Enrique Del Campo‐Herrera, Encarnación Clavijo, María D. García-Escaño, Juan Jesús Ruiz Ruiz, Mónica Morales-Herrera, Vanesa Valle-López, Rosa Martín-Alarcón, Isabel Viciana, Juan Bautista Jiménez, Félix Fernández-García, Juan Pedro Toro-Ortiz, Elena Sánchez-Yáñez, Ismael Álvarez‐Álvarez, Raúl J. Andrade, Mercedes Robles‐Díaz, Miren García‐Cortés   +20 more
openalex   +1 more source

Efficacy of Sequential Hepatic Vein Embolization Following Portal Vein Embolization in Promoting Regeneration of Liver Volume and Function Before Right‐Sided Major Hepatectomy

Annals of Gastroenterological Surgery, EarlyView.
Sequential hepatic vein embolization (HVE) following portal vein embolization (PVE) significantly improves both the volume and function of the future remnant liver (FRL) compared to PVE alone. In this study, the FRL regeneration rates for volume and function were markedly higher and faster in the PVE–HVE group, with no differences in surgical outcomes ...
Thanh Tung Lai, Kosuke Matsui, Hideyuki Matsushima, Hidekazu Yamamoto, Gozo Kiguchi, Hisashi Kosaka, Van Khanh Nguyen, Yasuhiro Ueno, Shuji Kariya, Masaki Kaibori   +9 more
wiley   +1 more source

State of Iowa Hepatitis C Virus End of Year 2016 Surveillance Report, [PDF]

, 2017
This end-of-year report presents surveillance data on hepatitis C in Iowa.

core  

Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling

, 2016
Abigail Jarret, Adelle P. McFarland, Stacy M. Horner, Alison M. Kell, Johannes Schwerk, MeeAe Hong, Samantha Badil, Rochelle C Joslyn, Darren P. Baker, Mary Carrington, Curt H. Hagedorn, Michael Gale, Ram Savan   +12 more
openalex   +1 more source

Inosine Triphosphate Pyrophosphatase Dephosphorylates Ribavirin Triphosphate and Reduced Enzymatic Activity Potentiates Mutagenesis in Hepatitis C Virus [PDF]

, 2018
Kristina Nystrôm, Paulina H. Wanrooij, J. Waldenström, Ludmila Adamek, Sofia Brunet, Joanna Said, Staffan Nilsson, Megan Wind‐Rotolo, Kristoffer Hellstrand, Heléne Norder, Ka‐Wei Tang, Martin Lagging   +11 more
openalex   +1 more source

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.

New England Journal of Medicine, 1998
J. Mchutchison, S. Gordon, E. Schiff, M. Shiffman, William M. Lee, V. Rustgi, Z. Goodman, M. Ling, S. Cort, J. Albrecht   +9 more
semanticscholar   +1 more source

Potential Survival Benefit of Adjuvant Chemotherapy in Stage IV Intrahepatic Cholangiocarcinoma: A Multicenter, Stage‐Stratified Analysis

Annals of Gastroenterological Surgery, EarlyView.
This multicenter study suggests that adjuvant chemotherapy may improve survival in stage IV intrahepatic cholangiocarcinoma after resection, with S‐1 showing a potential survival advantage. ABSTRACT Background The survival benefit of adjuvant chemotherapy (AC) in intrahepatic cholangiocarcinoma (ICC) remains uncertain, particularly in advanced‐stage ...
Hisashi Kosaka, Masaki Ueno, Hiroji Shinkawa, Yusuke Yamamoto, Masahiko Kinoshita, Koji Komeda, Tsukasa Aihara, Satoshi Yasuda, Haruki Mori, Masaki Kaibori   +9 more
wiley   +1 more source

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

Nature Medicine, 2005
T. Wakita, T. Pietschmann, Takanobu Kato, Takanobu Kato, T. Date, M. Miyamoto, Zijiang Zhao, K. Murthy, A. Habermann, H. Kräusslich, M. Mizokami, R. Bartenschlager, T. Liang   +12 more
semanticscholar   +1 more source

Combination of Ethoxybenzyl‐Diethylenetriamine Pentaacetic Acid‐Enhanced Magnetic Resonance Imaging and a Serum Biomarker Is Useful in the Diagnosis of Hepatic Sinusoidal Disorder After Chemotherapy Treatment

Annals of Gastroenterological Surgery, EarlyView.
ROC analyses of APRI score, EOB‐MRI, and a combination of EOB‐MRI and APRI score for blue liver. ABSTRACT Aim Sinusoidal obstruction syndrome (SOS), also known as “blue liver (BL),” is a common hepatic injury following oxaliplatin‐based chemotherapy in patients with colorectal liver metastases (CRLM).
Tomonari Shimagaki, Keishi Sugimachi, Takahiro Tomino, Takeshi Kurihara, Emi Onishi, Yutaro Shimomura, Kenji Shinozaki, Masaru Morita   +7 more
wiley   +1 more source